InvestorsHub Logo
Followers 185
Posts 2462
Boards Moderated 0
Alias Born 02/10/2017

Re: None

Tuesday, 01/12/2021 1:54:40 PM

Tuesday, January 12, 2021 1:54:40 PM

Post# of 241
Genome Stocks the next FANG stocks according to Cathie Wood of ARKG.

EVGN Quiet name getting ready to go surge to all time new highs of $6.00 will go parabolic soon!

Cathie Wood from ARKG ETF is investing in companies that she sees has exponential growth & scaling EVGN is one of those companies in her ARKG ETF where she highlights Gene editing & AI will be future underpinnings of successful companies EVGN is built around next level bleeding cutting edge Gene editing and AI technology.

Cathie Wood on Gene editing stocks in her ETF & recent success stories.

Shares are scarce only 35 million 45%+ owned by Insiders & institutions

most of the shares are accounted for and are being held by savvy investors. double digit dollars coming sooner than later.

one of my top picks for 2021

Evogene’s CPB based solutions utilize comprehensive and integrated computational biology to provide life-science companies with tailor-made solutions for product discovery and development.
Microbes, small molecules and genetic genome elements can be applied to a wide variety of products within human health, agriculture and industrial applications.


Gene editing AI platform applications for Biotech and agriculture.

Evogene group supports independent entities focusing on a defined commercial field with an exclusive license to use our unique solution for product development.

4.Lavie Bio

2021 Proof of concept, first-in-man study – Immuno-oncology program.

EVGN green gene editing product coming next year can be a blockbuster rivaling Monsantos Roundup which had billions yearly in sales from 2015.

What is an engineered green weed killer product worth in the market these days. coming to market in 2022

REHOVOT, Israel, Jan. 5, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across several market segments, provided today a year-end update for the CRISPR-IL consortium, of which it is a member and Evogene's CSO, Dr. Eyal Emmanuel, serves as the consortium's Chairman. The CRISPR-IL consortium, which is supported by the Israeli Innovation Authority, was established to develop an artificial intelligence-based system, for CRISPR-CAS based workflows, "Go-Genome", providing end-to-end genome-editing, with improved precision and efficiency.

Kathy Woods of ARKG ETF has been buying EVGN
Kathy woods from ARKG all star stock picker best in class

EVGN Biz Presentation

EVGN Subsidiary's which they own close to 100% in all
(1) Biomica Human Microbiome (gene editing)

Biomica Mission: Discovery and development of novel therapies for microbiome-related human disorders using computational predictive biology.

Medical Cannabis

Canonic Mission: Commercialization of precise & stable medical cannabis products for better therapeutic effects.


AgPlenus Mission: Design next generation effective, sustainable and safer crop protection products by leveraging predictive biology.

(4) Lavie Bio
Ag Biologicals

Lavie Bio Mission: Improve food quality, sustainability and agricultural productivity through the introduction of microbiome based ag-biological products.

Castor Oil Production

Castera Mission: Provide farmers with the most advanced Castor seeds & Ag-service solutions


2022 commercial product of a (Green) weed killer that will take market share from Monsanto round up massive revenue potential next year!

Oncology pipeline to kill tumors..

EVGN is a wealth creator buy what you can afford and lock up your shares GTC sky high.

Genome Stocks-Gene Editing.
$BEAM 5.4 billion market cap
$EDIT 4.8 billion market cap
$SGMO 2.3 billion market cap
$NTLA 4.8 billion market cap
$BLUE 3.3 billion market cap
$BNGO 1.2 billion market cap
$EVGN 180 million market cap 35 million shares 45% owned by institutions & insiders



Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EVGN News